Hs. Fischer et al., Retinoic acid treatment enhances the acetylcholine contents in the human teratocarcinoma cell line NTera-2, REGUL PEPT, 96(1-2), 2000, pp. 59-63
Human NTera-2/clone D1 teratocarcinoma cells are induced by retinoic acid (
RA) to differentiate into postmitotic cells with morphological and biochemi
cal characteristics of embryonic human neurones. Currently only limited inf
ormation concerning peptide-contents and neurotransmitter pools of these ce
lls is available. Zeller and Strauss [Int. J. Dev. Neurosci. 1995;13(5):437
] described an increase in choline acetyltransferase (ChAT) activity in RA-
treated, but not in untreated NTera-2 cells, suggesting the induction of a
cholinergic phenotype during treatment with RA. In the present study we inv
estigated the effect of RA-differentiation on the amount of the neurotransm
itters acetylcholine (ACh), and dopamine in NTera-2 in order to specify the
transmitter phenotype induced by RA-differentiation. We found that a 4-wee
k treatment of NTera-2 cells with 10 muM RA markedly increased the ACh-cont
ent of these cells, while dopamine levels were unchanged. Depolarisation wi
th potassium (60 mM) enhanced ACh-outflow in the differentiated cells in a
Ca++ dependent way. Also neuropeptides like substance P and NPY were detect
able in the undifferentiated NTera-2 cells, while vasointestinal peptide (V
IP) could not be found in either precursor or RA-differentiated cells. Diff
erentiation was accompanied by a marked reduction of neutral endopeptidase
enzyme activity and aminopeptidase activity. From these observations it was
concluded that RA induces a cholinergic neurochemical differentiation of t
his human teratocarcinoma cell line, and that these cells might provide a m
odel system to investigate cholinergic properties of human origin. (C) 2000
Elsevier Science B.V. All rights reserved.